UiPath (PATH) stock analysis: accelerating revenue and ARR near $2B with strong margins. Read the full analysis here.
Zacks Investment Research on MSNOpinion

Palantir vs. UiPath: Which AI-first software stock is a buy?

Both Palantir Technologies Inc. PLTR and UiPath Inc. PATH stand out as leading innovators in AI-driven software. Palantir has ...
UiPath Inc. (NYSE:PATH) is one of the 12 Best Mid-Cap AI Stocks to Buy According to Analysts. Raimo Lenschow from Barclays reaffirmed a Hold rating on UiPath Inc. (NYSE:PATH), along with the price ...
UiPath operates in enterprise software as automation, artificial intelligence, and digital workflows continue shaping ...
Investors might want to bet on UiPath (PATH), as earnings estimates for this company have been showing solid improvement ...
UiPath Inc. (NYSE:PATH) is one of the best long term stocks to buy under $20. BMO Capital cut the price target on UiPath Inc.
UiPath is pivoting toward AI-driven agentic automation but faces formidable competition from larger enterprise software peers ...
Together, UiPath and Deloitte will help organizations accelerate testing with agentic AI for enhanced resilience and innovation, enabling continuous autonomous quality UiPath (NYSE: PATH), a leader in ...
NYSE Composite attention highlighted UiPath activity as enterprise automation software, artificial intelligence integration, and workflow management systems remained central across technology markets ...
First, let's talk about why UiPath struggled so much during 2024. Its primary business is software for robotic process automation (RPA), which is used for automating repetitive tasks, such as an ...